LUNAI BIOWORKS INC

Investors face a steep plunge: Lunai Bioworks’ stock slumps 37%, dropping to $0.30 amid unmet biotech claims, risking total capital loss.

Nasdaq delisting forces Lunai Bioworks (LNAI) to exit the exchange, leaving investors to watch its shaky biotech prospects and limited liquidity.